Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

0.438
Delayed Data
As of 2:15pm ET
 -0.0399 / -8.35%
Today’s Change
0.40
Today|||52-Week Range
0.90
-35.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues6.3M5.3M5.2M3.8M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses468.0K583.0K516.0K213.0K
 
 
 
 
 
Total Operating Expenses468.0K583.0K516.0K213.0K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income5.8M4.7M4.7M3.6M
 
 
 
 
 
Extraordinary Charge--0.000.00-4.6M
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income5.8M4.7M4.7M-926.0K
 
 
 
 
 
Income Taxes0.00-2.5M-894.0K-888.0K
 
 
 
 
Net Income5.8M7.2M3.8M-1.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.2M44.2M44.2M44.2M
 
 
 
 
 
Shares To Calculate EPS Diluted44.2M44.2M44.2M44.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.13$0.16$0.09-$0.04
 
 
 
 
 
EPS Diluted$0.13$0.16$0.09-$0.04